Ashland Inc ASH

$72.99 -0.58 (-0.79%)

Valuation

Market cap
3,304,444,000
Revenue TTM
$1,824,000,000
Net income TTM
$-845,000,000
PE ratio
21.92
Forward PE
17.03
Profit margin
-46.33%
Debt to equity
0.73

Trading

Volume
427,340
Avg volume
574,178
Day's range
$72.11 – $73.47
Shares out
45,806,000
Stochastic %K
95%
Beta
0.40
Analysts
Strong Sell
Price target
$79.77

Price

Company profile

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutritio...

Show more

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

Industry
Specialty Chemicals
Sector
Basic Materials
Phone
302 995 3000
Website
https://www.ashland.com
Address
8145 Blazer Drive, Wilmington, United States

Latest news

Stocktwits

Theflash88 Oct 22, 9:35 PM
$ASH $88-94 a share. My guess.
0 replies
Mohossain Oct 17, 1:06 AM
Ashland ($ASH) sale process: CD&R + Clariant reportedly team up, with Apollo, Carlyle & CVC also circling. Initial bids reportedly landed Oct. 2. With bids in, is the debate no longer whether Ashland sells, but what EBITDA multiple clears the auction? https://seekingalpha.com/news/4650684-ashland-gains-on-report-bids-made-last-week%E2%80%94dealreporter #MergerArb #chemicals #deals #privateequity
0 replies
SlvrShroud94 Oct 17, 12:04 AM 0 replies
quezoitm Oct 16, 11:53 PM 0 replies
Mike22332233 Oct 16, 11:46 PM
$SLS 👉 URGENT UPDATE JUST IN ... 👉 👉 NEWS WHY STOCK MOVED DOWN SO MUCH ... Here is the news on SLS ... THERE IS NO NEWS AND NO CHANGE IN THE COMPANY AT ALL !!! The move down was caused by worries about the MRNA final readout next week and a GS analyst's negative thoughts about cancer vaccines and his price target "upped" to $137 on MRNA!!! ... Take a look at $MRNA on a minute-by-minute chart today .... EXACTLY the same move down, EXACTLY minute-by-minute !!!! I plowed all my profits of $103,637 from my 3 BUY OUTS of PRTH, BMBL & CCC these last couple of weeks (all of which I perfectly called -- thank you very much!!) into SLS today at $9.86-$10.03 !!! I hope I get a chance to buy more with my next batch of BUY OUTS -- DDD, $ASH, $QGEN, $GFL -- all of which I expect to be taken out within the next 30 days !!! LIKE & FOLLOW 👉@Mike22332233 for further info
1 replies
Markus01 Oct 7, 5:45 PM
$ASH Long term chart 👀 I expect price to be in Wave B within a flat correction. I'm not interested in buying unless price retests the 200WMA or once Wave C completes. This one will take some time to play out, but it will be worth the wait.
0 replies
MaybeBaybe Sep 17, 4:46 PM
$ASH Long, small, filled ~$70. Bloomberg Aug 7: exploring sale, bids reportedly due this month — Apollo, Carlyle, Advent, Standard Industries. What I actually looked at: Standard already owns ~10% at $54 avg. Ancora settled in July and put two directors on the board whose résumé is "sold a specialty chem company" (ex-Ferro CEO, ex-Hercules CFO). Zero insider sales in 651 days. 3,500 Oct 75–90 calls in OI. Dark pool close program the last two sessions. Stock sits at standalone fair value (~$70) — market pricing zero for the process. Deal = $85–92. No deal = $65. Stop under $64.50, out Oct 17 if nothing happens. ~55/45.
0 replies
Mike22332233 Sep 10, 3:55 PM
$CCCS 👉 8 BUY OUTs in 8 Months ... I Will Almost Guarantee It !!!! EIGHT, or more, of the following of my Special Situation Stocks will be Bought Out: 1) SLS 2) INBX 3) PRTH 4) DDI 5) MNRO 6) RYAM 7) CRTO 8) GFL 9) $IMXI 10) QGEN 11) PBI 12) $BVS 13) $ASH 14) CCCS LIKE & FOLLOW Me 👉@Mike22332233 for the latest updates on each !!!
1 replies